Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Neurocrine Biosciences Inc (NBIX) has a market cap of $13.13B with year-over-year revenue growth of +21.4%. Net margin stands at 16.7%. The stock trades at a P/E ratio of 27.4.
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, NBIX posted revenue growth of +21.4% and trades at a P/E of 27.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.